Navigation Links
Keryx Biopharmaceuticals Receives Nasdaq Notification
Date:11/21/2008

NEW YORK, Nov. 21 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that on November 17, 2008, it received notice from The Nasdaq Stock Market ("Nasdaq") stating that the Company is no longer in compliance with Marketplace Rule 4310(c)(3), which requires the Company to have a minimum of $2,500,000 in stockholders' equity, or $35,000,000 market value of listed securities, or $500,000 of net income from continuing operations for the most recently completed fiscal year or two of the three most recently completed fiscal years, for continued listing on The Nasdaq Capital Market.

In the letter, Nasdaq Staff requested that the Company provide, on or before December 2, 2008, a specific plan to achieve and sustain compliance with all of The Nasdaq Capital Market listing requirements, and the time frame required for completion of the plan. The Company is preparing its plan for submission to Nasdaq by the specified date.

If, after the conclusion of the review process, Nasdaq Staff determines that the Company has not presented an adequate plan to address the issues noted, the Nasdaq Staff will provide the Company with written notification that its securities will be delisted. The Company may then appeal the Nasdaq Staff's decision to a Nasdaq Listing Qualifications Panel.

The notification from Nasdaq has no effect at this time on the continued listing of Keryx Biopharmaceuticals' common stock on The Nasdaq Capital Market.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM) (ferric citrate), an oral, iron-b
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
2. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
3. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
4. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
5. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
6. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
7. Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis
8. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
9. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
10. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
11. Kaiser Permanente Receives the Most Stars in California Office of Patient Advocates Annual Quality Report Card
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... The Beryl Institute announces its fifth annual ... Program. These offerings reinforce the Institute’s commitment to support ... and the need for rigorous research to understand and ... programs are intended to encourage and support research ... on the patient experience before, during and after care ...
(Date:7/22/2014)... Ticket Down is a reliable source for cheap ... Landover, MD. There has never been a better time in ... the success of the American national soccer team at the 2014 ... way that fans of the world’s sport will be able to ... International Champions Cup. The tournament will kick off on July 24 ...
(Date:7/22/2014)... New York, NY (PRWEB) July 22, 2014 ... Risperdal lawsuits ( http://www.risperdallawsuitcenter.com/ ) in ... his decision to deny punitive damages in cases ... (male breast growth), Bernstein Liebhard LLP reports. In ... New also denied a plaintiffs’ request to certify ...
(Date:7/22/2014)... Angeles, CA (PRWEB) July 22, 2014 ... the way in providing resources, educational tools and recognition ... tell the stories of prevention, treatment and recovery. On ... BLACK BOX will spotlight some of these resources with ... Health Services Administration helpline and treatment website at the ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 The park ... at the Kendalltown Homeowners Association, Inc., made ... its residential community with the purchase of playground equipment ... is located in beautiful Miami Florida, and is a ... maturity of the surrounding landscape has created a tropical ...
Breaking Medicine News(10 mins):Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 3Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 3Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 4Health News:ABC’s BLACK BOX Spotlights Mental Health and Available Resources in Upcoming Episode 2Health News:Fun in the Florida Sun: Kendalltown Homeowners Association Inc. Expands Outdoor Recreation with American Parks Company™ 2Health News:Fun in the Florida Sun: Kendalltown Homeowners Association Inc. Expands Outdoor Recreation with American Parks Company™ 3
... , MONDAY, April 18 (HealthDay News) -- Hospitals are ... not have hemophilia, a rare disorder in which blood does ... patients is potentially risky, according to new research. Stanford ... recombinant factor 7a, grew by 140 times from use in ...
... HealthDay Reporter , MONDAY, April 18 (HealthDay News) -- Gay ... live in communities where they feel they have some support, ... same-sex couples live in the area, new research has found. ... Pediatrics , lesbian, gay and bisexual (LGB) youths who ...
... , MONDAY, April 18 (HealthDay News) -- Most people with ... their ability to smell anything at all -- adjust and learn ... usually appear to place less importance on the sense of smell ... smell. The study included 470 people, half who either lacked ...
... April 18 (HealthDay News) -- Healthy lifestyle changes can ... blood fat associated with heart disease and other health ... Monday. About one-third (31 percent) of adults in ... more than 150 milligrams per deciliter (mg/dL). These ...
... list, can reduce problems with recurring low back pain, reveals ... people suffer with low back pain, and most get better. ... their work, everyday and leisure activities are limited to varying ... is important that the pain be treated at an early ...
... of every 6 kids in the United States, in part ... play a key part in offering elementary-age kids lots of ... they,re in gym. But recent increasing expectations about academic ... cut back on both recess and gym class. The ...
Cached Medicine News:Health News:Off-Label Use of Clotting Drug Soars, Report Finds 2Health News:Support May Help Curb Suicide Among Gay Youths 2Health News:Support May Help Curb Suicide Among Gay Youths 3Health News:Poor Sense of Smell Not a Big Loss for Most People: Study 2Health News:Lifestyle Changes Can Slash Blood Fat Levels, Experts Say 2Health News:Immediate treatment can alleviate future back problems 2Health News:U-M experts: Gym gone but not forgotten? Parents want more physical activity at school for kids 2
(Date:7/22/2014)... July 22, 2014  Decision Resources Group finds that the ... will remain relatively stagnant at a value of ... that percutaneous coronary intervention (PCI) volumes are growing faster in ... such as the United States and ... driven by the increase in penetration of PCI procedures relative ...
(Date:7/22/2014)... WASHINGTON , July 22, 2014 ... "Ensuring Seniors Access to Local Pharmacies Act of ... Medicare Part D would undermine the availability of ... spending by $21 billion over the next 10 ... Company released by the Pharmaceutical Care Management Association ...
(Date:7/22/2014)... July 22, 2014  Decision Resources Group finds ... (MS) patients currently treated with Biogen Idec,s ... experienced flushing and/or gastrointestinal events while on ... currently experiencing these side effects, signifying either ... management of such events. In the end, ...
Breaking Medicine Technology:The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 3New Study: H.R. 4577 to Cost $21 Billion over 10 Years 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 3Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 3
... Pa., Dec. 29, 2010 Endo Pharmaceuticals (Nasdaq: ... and Drug Administration (FDA) has approved FORTESTA Gel for ... known as hypogonadism. Symptoms associated with Low T include ... of energy, mood depression, regression of secondary sexual characteristics ...
... Dr. David Samadi, the Vice Chairman, Department of Urology, ... The Mount Sinai Medical Center in New York City, ... completion of six successful robotic prostate cancer treatment ... three of which were televised live, Samadi demonstrated his ...
Cached Medicine Technology:Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone 2Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone 3Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone 4Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone 5Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone 6Robotic Surgery Expert Dr. David Samadi, MD Determines Live Robotic Prostate Cancer Surgeries During Israel Trip A Success 2Robotic Surgery Expert Dr. David Samadi, MD Determines Live Robotic Prostate Cancer Surgeries During Israel Trip A Success 3
... is designed for arthroscopic or open suturing ... It features heavy-gauge suture hooks and the ... hooks allow precise suture placement in otherwise ... System is for use with #2/0 to ...
Suture Cutter, 15 Up Curve...
Portal accessory instrument set. Set also includes a package of 8 mm Guide Wires (.15 cm x 38 cm), and Sterilization Tray....
...
Medicine Products: